Latest news
AtaiBeckley (ATAI) Gains On Earnings Revisions, Is The Premium Valuation Justified? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 05:45:45 GMTPα+ Psychedelic Bulletin #229: SAMHSA Convenes Experts; AtaiBeckley’s Road to Lilly; Turnbull Doubles Down on BOL-148; Compass Talks Indication Expansion, Could VA Help? - Psychedelic AlphaPsychedelic Alpha · Fri, 07 Aug 2026 15:47:36 GMTEli Lilly to Acquire AtaiBeckley to Expand Mental Health Pipeline - The Healthcare Technology Report.The Healthcare Technology Report. · Tue, 04 Aug 2026 12:03:07 GMTAtaiBeckley attracted co-development and royalty offers before $2.8B Lilly deal - Endpoints NewsEndpoints News · Fri, 31 Jul 2026 07:00:00 GMTEli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet. - The Motley FoolThe Motley Fool · Wed, 29 Jul 2026 07:00:00 GMTTracking Cathie Wood: Slashing AtaiBeckley and Figma, Betting on Gene-Editor Scribe Therapeutics - MoomooMoomoo · Mon, 27 Jul 2026 08:53:43 GMT